Peloton Equity Closes Fund With $152 Million

McGuireWoods LLP
Contact

Peloton Equity has announced it has closed its second fund, Peloton Equity II, with about $152 million in limited partner and general partner commitments.

Peloton, based in Greenwich, Conn., is a healthcare-focused private equity firm focused exclusively on growth capital investments across a wide range of healthcare sectors. The firm targets companies with $20 million to $200 million in revenue at investment.

Peloton has thus far completed three investments out of the new fund: ClearSky Health, a provider of inpatient rehabilitation and related post-acute care services to patients in need of intensive care following an acute event; AeroSafe Global, a provider of cold chain packaging and logistics solutions to the pharmaceutical, biopharmaceutical, specialty pharmacy and medical device industries; and Friday Health Plans, a provider of consumer-oriented health plans to individuals and small groups in Colorado, Nevada, New Mexico and Texas.

The firm announced that commitments to Peloton Equity II came from a diverse set of investors, including healthcare organizations, financial institutions, fund of funds, family offices and individuals.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP
Contact
more
less

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.